Indeed, our in vivo study revealed notable differences in efficacy, where treatment with ATG5-knockout CAR-T cells elicited an immediate reduction in tumor growth, followed by rapid tumor clearance and complete remission in all mice. This evidence concerns the gene ATG5 and neoplasm.